P89 IL-28 as potential therapeutic target for LN

• Andreas Schwarting,
• Tamara Möckel,
• Myriam Meineck,
• Julia Weinmann-Menke,
• Andreas Kommer,
• Sebastian Linsel,
• Sabrina Saurin,
• Andrea Pautz

Affiliations

Andreas Schwarting

Center for Rheumatology Rhineland-Palatinate, Bad Kreuznach, Germany

Tamara Möckel

1 Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

Myriam Meineck

1First Dept. of Medicine, University Medicine of the Johannes Gutenberg University, Mainz, Germany

Julia Weinmann-Menke

1st Department of Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Andreas Kommer

1First Dept. of Medicine, University Medicine of the Johannes Gutenberg University, Mainz, Germany

Sebastian Linsel

1First Dept. of Medicine, University Medicine of the Johannes Gutenberg University, Mainz, Germany

Sabrina Saurin

1First Dept. of Medicine, University Medicine of the Johannes Gutenberg University, Mainz, Germany

Andrea Pautz

2Institute of Pharmacology, University Medicine of the Johannes Gutenberg University, Mainz, Germany